Insider Transactions in Q1 2023 at Hologic Inc (HOLX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2023
|
Stacey D. Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+45.82%
|
-
|
|
Mar 09
2023
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+7.1%
|
-
|
|
Mar 09
2023
|
Ludwig Hantson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+13.34%
|
-
|
|
Mar 09
2023
|
Namal Nawana Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+7.44%
|
-
|
|
Mar 09
2023
|
Christiana Stamoulis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+3.23%
|
-
|
|
Mar 09
2023
|
Sally Crawford Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+1.1%
|
-
|
|
Mar 09
2023
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+17.89%
|
-
|
|
Mar 09
2023
|
Scott T Garrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+2.14%
|
-
|
|
Mar 01
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-3.56%
|
$30,099
$79.06 P/Share
|
|
Feb 07
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,128
-38.97%
|
$775,880
$85.28 P/Share
|
|
Feb 07
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,128
+28.04%
|
$365,120
$40.97 P/Share
|
|
Feb 07
2023
|
Charles J Dockendorff Director |
SELL
Bona fide gift
|
Indirect |
1,336
-100.0%
|
-
|
|
Jan 02
2023
|
Stacey D. Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
267
+50.0%
|
-
|